Goldline Pharmaceutical IPO Allotment Status: Here’s How to Check Allotment Online

As on 14 May 2026, 5PM IST, The allotment of shares for Goldline Pharmaceutical IPO of ₹11.61 crores is expected to take place on 15 May 2026. The subscription for the Goldline Pharmaceutical IPO closed on 14 May 2026. The IPO ran from 12 May 2026 to 14 May 2026 and was priced between ₹41 and ₹43 per share. The Goldline Pharmaceutical IPO comprised a fresh issue and an offer for sale.

Goldline Pharmaceutical IPO subscribed 762.23 times. The public issue subscribed 845.9 times in the individual investors category, 173.44 times in QIB (Ex Anchor), and 1221.79 times in the NII category by 14 May 2026, 5PM on Day 3.

How to check Goldline Pharmaceutical IPO Allotment Status on Registrar site

Step 1: Visit Bigshare Services Private Limited
Step 2: Select Goldline Pharmaceutical from the drop-down menu on the page
Step 3: Enter details required like PAN number, Application Number, or Demat Account Number.
Step 4: Click on the ‘Search’ Button
Step 5: Get your allotment status

How to check Goldline Pharmaceutical IPO Allotment Status on BSE website

Step 1: Go to the BSE website
Step 2: Click on ‘Status of Issue Application’ under ‘Investor Services’
Step 3: Click on ‘Application Status Check’
Step 4: Choose the ‘Issue Type’ and ‘Issue Name’
Step 5: Enter your PAN or Application Number
Step 6: Verify the box ‘I’m not a robot’
Step 7: Click on “Search to view allotment status”

How to check Goldline Pharmaceutical IPO Allotment Status on NSE website

Step 1: Open NSE INDIA website in your browser.
Step 2: In the top menu, click on Invest (or search for “Verify IPO Bids”)
Step 3: Under Resources & Tools, select “Verify IPO Bids / IPO Bid Verification”
Step 4: On the IPO Bid Verification page, select the Goldline Pharmaceutical from the dropdown
Step 5: Enter your Application Number or PAN in the required field
Step 6: Fill any other required fields (e.g., DP ID if requested)
Step 7: Complete the CAPTCHA / “I’m not a robot” check
Step 8: Click Submit (or Verify) to view your Goldline Pharmaceutical allotment status.

About Goldline Pharmaceutical

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the Goldline brand are not manufactured by Company. Instead, they enter into contractual arrangements with thirdparty manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence.Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency.Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.

What happens if you get the Goldline Pharmaceutical share allotment?

If you are allotted the Goldline Pharmaceutical shares on 19 May 2026, the allotment day, the shares will be credited to your demat account on 18 May 2026. The money that was blocked for them will be debited from your linked bank account. Once you receive the shares, you can trade them or sell them after they are listed on 19 May 2026, on NSE or BSE.

What if you didn’t get the Goldline Pharmaceutical IPO allotment?

If you didn’t receive allotment:
• Refunds will be initiated on or about 18 May 2026.
• The amount will be credited to your bank account linked to UPI On the other hand, if allotted shares will reflect in your Demat by 15 May 2026.

When is Goldline Pharmaceutical listing on the exchanges?

The shares of Goldline Pharmaceutical are expected to be listed on BSE and NSE on or about 19 May 2026. You can track listing gains/losses on Kotak Neo.